Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ChromaDex Q4 2024 GAAP EPS $0.09 Beats $0.02 Estimate, Sales $29.125M Beat $26.733M Estimate

Author: Benzinga Newsdesk | March 04, 2025 04:06pm
ChromaDex (NASDAQ:CDXC) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $0.02 by 350 percent. The company reported quarterly sales of $29.125 million which beat the analyst consensus estimate of $26.733 million by 8.95 percent. This is a 37.41 percent increase over sales of $21.196 million the same period last year.

Posted In: CDXC


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist